Glassbox Structural Transparency in Pharmaceutical Research A Constraint-Mediated Stability Framework for Institutional Research Use
Year: 2026
Type: article
Abstract: Pharmaceutical research routinely relies on mean-based statistical reporting to summarise trialoutcomes. While this approach provides aggregate clarity, it compresses subgroup-level variance,masking interaction topologies, non-linear dose-response relationships, and noise amplificationeffects that may be material to research interpretation. This paper proposes a conceptualframework, termed Glassbox Structural Transparency, which applies constraint-mediatedstability analysis to pharmaceutical research datasets as an additional analytical layer. Theframework does not replace existing statistical methodologies; it supplements them by exposingstructural variance that mean-based reporting may compress. This is a research-onlycontribution. It carries no clinical intent, no commercial application, and no advisory function.Empirical instantiation across specific therapeutic domains is required before any conclusionsregarding utility can be drawn.
Authors: Smith, John Richard, SHAI / HATI
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W7131131982
FWCI:
Cites:
Cited by:
Related to: